Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are older than 40 years of age
- People who have a confirmed diagnosis of Amyloidosis (either ATTR or AL type)
- Women who have had a negative pregnancy test taken less than a specified number of weeks before the imaging scan (confirm with trial site for exact timeframe)
Who may not be able to join:
- People who have already started receiving treatment specifically for Amyloidosis before joining the study
- People who are currently taking part in another clinical trial for the treatment of Amyloidosis
- People who are pregnant
- People for whom an MRI scan is not considered safe, including those with kidney function below a certain level (eGFR below 30ml/min/1.73m²), an allergy to gadolinium (a contrast dye used in MRI), or certain metallic implants or devices that are not compatible with a 3T MRI machine
- People who are not able to give informed consent to participate
- People who choose not to give their consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +492017232073
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Occurence of MACE
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.